We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-4.09%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.52B
AUM Growth
-$173M
Cap. Flow
-$49.9M
Cap. Flow %
-1.98%
Top 10 Hldgs %
37.25%
Holding
3,473
New
219
Increased
908
Reduced
1,468
Closed
292

Sector Composition

Rank Sector Weight
1 Technology 15.38%
2 Financials 8.17%
3 Healthcare 7.07%
4 Consumer Discretionary 4.99%
5 Communication Services 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AQN icon
2951
Algonquin Power & Utilities
AQN
$4.42B
$0 ﹤0.01%
+8
New +$115
AR icon
2952
Antero Resources
AR
$10.7B
$0 ﹤0.01%
+4
New +$90
ARCT icon
2953
Arcturus Therapeutics
ARCT
$211M
$0 ﹤0.01%
17
-58
-77% -$1.48K
ARLO icon
2954
Arlo Technologies
ARLO
$1.65B
-17
Closed
ASO icon
2955
Academy Sports + Outdoors
ASO
$2.98B
-3
Closed
ATEC icon
2956
Alphatec Holdings
ATEC
$1.44B
-13
Closed
LONA
2957
LeonaBio Inc
LONA
$72.1M
-20
Closed -$3K
ATLC icon
2958
Atlanticus Holdings
ATLC
$1.52B
$0 ﹤0.01%
3
ATOM icon
2959
Atomera
ATOM
$214M
-152
Closed -$3K
AUR icon
2960
Aurora
AUR
$13.8B
$0 ﹤0.01%
30
AVA icon
2961
Avista
AVA
$3.24B
$0 ﹤0.01%
6
AVIR icon
2962
Atea Pharmaceuticals
AVIR
$420M
-35
Closed
AVSF icon
2963
Avantis Short-Term Fixed Income ETF
AVSF
$654M
-1,480
Closed -$71.7K
AVTX icon
2964
Avalo Therapeutics
AVTX
$983M
0
AVXL icon
2965
Anavex Life Sciences
AVXL
$310M
$0 ﹤0.01%
17
-78
-82% -$959
DCH
2966
Dauch Corp
DCH
$1.51B
$0 ﹤0.01%
19
-31
-62% -$264
AXSM icon
2967
Axsome Therapeutics
AXSM
$10.9B
-92
Closed -$3K
AZUL
2968
DELISTED
Azul
AZUL
$0 ﹤0.01%
4
BAB icon
2969
Invesco Taxable Municipal Bond ETF
BAB
$1.01B
$0 ﹤0.01%
16
BATRA icon
2970
Atlanta Braves Holdings Series A
BATRA
$3.43B
$0 ﹤0.01%
11
-25
-69% -$675
BBIO icon
2971
BridgeBio Pharma
BBIO
$16.5B
-121
Closed -$2K
BCRX icon
2972
BioCryst Pharmaceuticals
BCRX
$2.4B
$0 ﹤0.01%
+9
New +$144
BCYC
2973
Bicycle Therapeutics
BCYC
$292M
$0 ﹤0.01%
5
BDC icon
2974
Belden
BDC
$5.19B
$0 ﹤0.01%
3
-2
-40% -$115
BEKE icon
2975
KE Holdings
BEKE
$18.8B
-19
Closed

Similar funds

Parallel Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Parallel Advisors held 3,473 positions worth $2.52B, down 6.4% from $2.69B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors's Q1 2022 filing shows 219 new, 908 increased, 1,468 reduced and 292 closed positions. Its largest new stake was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M. The largest sale was Vanguard ESG US Stock ETF, an estimated $9.63M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

  • Parallel Advisors's largest Q1 2022 buy was eFFECTOR Therapeutics, Inc. Common Stock: 27,098 shares worth $2.74M.
  • Parallel Advisors added most to iShares Fallen Angels USD Bond ETF in Q1 2022, an estimated $9.31M increase.
  • Parallel Advisors's biggest Q1 2022 reduction was Vanguard ESG US Stock ETF, cutting an estimated $9.63M.
  • Parallel Advisors fully exited State Street SPDR Nuveen ICE Short Term Municipal Bond ETF in Q1 2022, selling an estimated $1.09M.
  • Parallel Advisors's ten largest holdings make up 37% of its $2.52B portfolio in Q1 2022.
  • Parallel Advisors opened 219 new positions and closed 292 in Q1 2022.
  • Parallel Advisors's portfolio value fell 6.4% quarter-over-quarter to $2.52B.

Based on Parallel Advisors's 13F filing for Q1 2022, filed 28 Apr 2022.